Literature DB >> 17129072

Do pharmacogenomic tests provide value to policy makers?

Ya-Chen Tina Shih, Lajos Pusztai.   

Abstract

Mesh：

Year:  2006        PMID： 17129072     DOI： 10.2165/00019053-200624120-00002

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  7 in total

1.  Bayesian approaches to the value of information: implications for the regulation of new pharmaceuticals.

Authors:  K Claxton
Journal:  Health Econ       Date:  1999-05       Impact factor: 3.046

2.  Pharmacogenomics and the evolution of healthcare : is it time for cost-effectiveness analysis at the individual level?

Authors:  Mohan V Bala; Gary A Zarkin
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

3.  Does pharmacogenomics provide an ethical challenge to the utilisation of cost-effectiveness analysis by public health systems?

Authors:  Adam La Caze
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 4.  Individualized chemotherapy treatment for breast cancer: is it necessary? Is it feasible?

Authors:  Lajos Pusztai; Roman Rouzier; Peter Wagner; W Fraser Symmans
Journal:  Drug Resist Updat       Date:  2004-12-21       Impact factor: 18.500

5.  Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.

Authors:  Soonmyung Paik; Gong Tang; Steven Shak; Chungyeul Kim; Joffre Baker; Wanseop Kim; Maureen Cronin; Frederick L Baehner; Drew Watson; John Bryant; Joseph P Costantino; Charles E Geyer; D Lawrence Wickerham; Norman Wolmark
Journal:  J Clin Oncol       Date:  2006-05-23       Impact factor: 44.544

6.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

Authors:  Soonmyung Paik; Steven Shak; Gong Tang; Chungyeul Kim; Joffre Baker; Maureen Cronin; Frederick L Baehner; Michael G Walker; Drew Watson; Taesung Park; William Hiller; Edwin R Fisher; D Lawrence Wickerham; John Bryant; Norman Wolmark
Journal:  N Engl J Med       Date:  2004-12-10       Impact factor: 91.245

7.  Decision analysis: introductory lectures on choices under uncertainty. 1968.

Authors:  H Raiffa
Journal:  MD Comput       Date:  1993 Sep-Oct
  7 in total
  1 in total

1.  Letter from the Commissioner's Office at the US FDA.

Authors:  John A Vernon
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.